Skip to content

13F-HR filed by Prosight Management, LP

Prosight Management, LP filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 38 holding rows worth $186,656,000.

Accession
0001420506-22-002133
Filed
2022-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, 38 entries on the cover page, a total value of $186,656,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $186,656,000 with VALUE read as thousands by filing date, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PROTHENA CORP PLC SHSG72800108Stock321,093$19,468,000thousands by filing date
HORIZON THERAPEUTICS PLCG46188101SHS303,000$18,753,000thousands by filing date
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR405,000$17,269,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM1,327,899$11,433,000thousands by filing date
ALKERMES PLCG01767105SHS502,150$11,213,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK491,244$9,510,000thousands by filing date
MEIRAGTX HOLDINGS PLCG59665102COMMON STOCK1,103,365$9,279,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM530,062$7,691,000thousands by filing date
CHARLES RIV LABS INTL INC159864107COM33,220$6,538,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM1,210,800$6,466,000thousands by filing date
HUMANA INC COM444859102Stock12,800$6,210,000thousands by filing date
MIRUM PHARMACEUTICALS INC604749101COM285,000$5,988,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock102,000$5,261,000thousands by filing date
Johnson & Johnson478160104COM31,704$5,179,000thousands by filing date
QUIDELORTHO CORP COM219798105Stock62,900$4,496,000thousands by filing date
CUE BIOPHARMA INC22978P106COM1,545,573$3,447,000thousands by filing date
PROTHENA CORP PLCG72800908SHS53,100$3,219,000thousands by filing datecall
ROCKET PHARMACEUTICALS INC77313F106COM200,000$3,192,000thousands by filing date
SHATTUCK LABS INC82024L103COMMON STOCK1,120,776$3,026,000thousands by filing date
ORIC PHARMACEUTICALS INC68622P109COM936,334$2,996,000thousands by filing date
INCYTE CORP COM45337C102Stock40,450$2,696,000thousands by filing date
OMNICELL COM COM68213N109Stock30,700$2,672,000thousands by filing date
AVANTOR INC COM05352A100Stock122,668$2,404,000thousands by filing date
BAXTER INTL INC071813109COM39,000$2,101,000thousands by filing date
RHYTHM PHARMACEUTICALS INC76243J105COM80,000$1,960,000thousands by filing date
1LIFE HEALTHCARE INC68269G107COM106,200$1,821,000thousands by filing date
FILANA THERAPEUTICS INC14817C957COM35,900$1,501,000thousands by filing dateput
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock113,800$1,434,000thousands by filing date
ARDELYX INC039697107COM1,126,127$1,340,000thousands by filing date
EVOLUS INC30052C107COM160,200$1,290,000thousands by filing date
PROQR THERAPEUTICS NVN71542109SHS EURO1,716,290$1,277,000thousands by filing date
ADC THERAPEUTICS SAH0036K147COMMON STOCK247,630$1,194,000thousands by filing date
GRAPHITE BIO INC38870X104COM356,445$1,130,000thousands by filing date
ARS PHARMACEUTICALS INC82835W108COM196,257$1,036,000thousands by filing date
ABCELLERA BIOLOGICS INC COM00288U106Stock86,504$856,000thousands by filing date
R1 RCM INC77634L105COM32,113$595,000thousands by filing date
SPOK HLDGS INC COM84863T106Stock65,000$497,000thousands by filing date
MARAVAI LIFESCIENCES HLDGS A56600D107COMMON STOCK8,540$218,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-22-002133this filing2022-11-14acceptance time not in the bulk data set